Date: Wednesday 04 Apr 2012
LONDON (ShareCast) - AKAMAI TECHNOLOGIES: DA Davidson upgrades to buy from neutral, price target of $45 (vs. $40).
BIOGEN IDEC: Goldman Sachs upgrades to buy from neutral, price target of $150 (vs. $120).
CSX: Atlantic Equities upgrades to overweight from neutral, price target of $26.59 (vs. $23.50).
GAP: Piper Jaffray upgrades to overweight from neutral.
IBM: Bank of America Merrill Lynch downgrades to neutral from buy.
MCDONALD'S: Goldman Sachs removes from its Conviction Buy list.
PROGRESSIVE: Bank of America Merrill Lynch downgrades to neutral from buy.
SANDISK: Sterne Agee reiterates buy, price target of $55 (vs. $57).
STARBUCKS: Goldman Sachs upgrades to buy from neutral, includes stock on its Conviction Buy list, price target of $66 (vs. $49).
TIFFANY & CO: Oppenheimer reiterates overweight, price target of $83 (vs. $75).
C.S.
Email this article to a friend
or share it with one of these popular networks:
| Currency | US Dollars |
| Share Price | $ 41.36 |
| Change Today | $ 0.32 |
| % Change | 0.78 % |
| 52 Week High | $41.67 |
| 52 Week Low | $25.26 |
| Volume | 3,948,757 |
| Shares Issued | 465.30m |
| Market Cap | $19,245m |
| Beta | 0.89 |
| RiskGrade | 125 |
| Strong Buy | 14 |
| Buy | 0 |
| Neutral | 15 |
| Sell | 1 |
| Strong Sell | 1 |
| Total | 31 |

| Time | Volume / Share Price |
| 16:05 | 90,937 @ $41.36 |
| 15:59 | 100 @ $41.38 |
| 15:59 | 273 @ $41.38 |
| 15:59 | 300 @ $41.37 |
| 15:59 | 100 @ $41.38 |
You are here: research